Scarica l'app Stockscreener
0.864
5.10%
0.0419
Pre-mercato:
.89
0.026
+3.01%
AEON Biopharma Inc. Borsa (AEON) Ultime notizie
AEON Biopharma announces execution of exchange agreement with Daewoong Pharmaceutical - MSN
Aeon Biopharma announces execution of exchange agreement with Daewoong - marketscreener.com
AEON Biopharma Announces Exchange Agreement with Daewoong - TipRanks
AEON Biopharma signs Daewoong note exchange with equity and warrants | AEON SEC FilingForm 8-K - Stock Titan
AEON Biopharma (NYSE: AEON) agrees Daewoong swap cutting over 90% of debt - Stock Titan
Aeon Biopharma Continues Push to Commercialization - Orange County Business Journal
AEON Biopharma (AEON) Price Target Decreased by 15.28% to 6.22 - Nasdaq
How AEON Biopharma Inc. Class stock performs in volatility spikesQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
Can AEON Biopharma Inc. Class stock retain market dominanceJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
AEON Biopharma Releases New Corporate Presentation - TipRanks
AEON Biopharma : Corporate Presentation - marketscreener.com
AEON Biopharma (NYSE: AEON) releases new investor Corporate Presentation - Stock Titan
AEON Biopharma, Inc. Releases Corporate Presentation on Biosimilar Development - TradingView
Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight - GlobeNewswire Inc.
Aeon Biopharma Reports Positive Data and Strategic Moves - MSN
Aeon Secures Funding As FDA Sets New Date For Botox Biosimilar Review - Citeline News & Insights
Check out these key findings about AEON Biopharma Inc (AEON) - Setenews
How AEON Biopharma Inc. Class stock valuation compares with sector2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
AEON Biopharma (NASDAQ:AEON) Upgraded at Zacks Research - Defense World
Aeon Biopharma announces first closing of PIPE investment and provides update on FDA Type 2A meeting scheduling - MarketScreener
Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling - TradingView
AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling - The Manila Times
AEON Biopharma Inc: FDA Bpd Type 2a Meeting N - 富途牛牛
Can AEON Biopharma Inc. Class stock survive global slowdownWeekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com
Will AEON Biopharma Inc. Class stock beat international competitionWeekly Earnings Recap & Capital Protection Trading Alerts - newser.com
Applying big data sentiment scoring on AEON Biopharma Inc.July 2025 PostEarnings & Verified Short-Term Plans - newser.com
Why AEON Biopharma Inc. Class stock signals breakout potentialPortfolio Gains Summary & Smart Allocation Stock Reports - newser.com
Will AEON Biopharma Inc. Class stock announce special dividendBreakout Watch & Verified High Yield Trade Plans - newser.com
Will AEON Biopharma Inc. Class stock return to pre crash levelsTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com
What earnings margins imply for AEON Biopharma Inc. Class stockMarket Performance Summary & AI Enhanced Trade Execution Alerts - newser.com
Is AEON Biopharma Inc. Class stock among top earnings plays2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
How forex fluctuations impact AEON Biopharma Inc. Class stockJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com
Will AEON Biopharma Inc. price bounce be sustainableJuly 2025 Technicals & Expert Curated Trade Setup Alerts - newser.com
Can AEON Biopharma Inc. stock resist market sell offs - newser.com
Published on: 2025-11-19 04:38:24 - newser.com
How big funds are accumulating AEON Biopharma Inc. Class stock2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Relative strength of AEON Biopharma Inc. in sector analysisTrade Entry Report & Consistent Profit Alerts - newser.com
Is AEON Biopharma Inc. stock attractive for ETFsQuarterly Profit Summary & Verified Entry Point Signals - newser.com
0.36%
1.05%
Capitalizzazione:
|
Volume (24 ore):